Related Experiment Videos
Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis
L Fugger1, N Morling, M Sandberg-Wollheim
1Department of Clinical Immunology, State University Hospital (Rigshospitalet), Copenhagen, Denmark.
Journal of Neuroimmunology
|April 1, 1990
Summary
The NcoI tumor necrosis factor (TNF alpha) polymorphism showed no significant differences in frequency between multiple sclerosis patients and healthy individuals. This genetic marker is not associated with increased risk for these neurological conditions.
Area of Science:
- Genetics
- Neuroimmunology
- Molecular Biology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- Tumor necrosis factor alpha (TNF alpha) is a key cytokine implicated in inflammatory processes, including MS pathogenesis.
- Genetic variations, such as polymorphisms in the TNF alpha gene, may influence susceptibility to autoimmune diseases.
Purpose of the Study:
- To investigate the association between the NcoI polymorphism of the tumor necrosis factor (TNF alpha) gene and the risk of developing relapsing/remitting multiple sclerosis (RRMS) and monosymptomatic optic neuritis (MON).
- To determine if specific NcoI marker phenotypes are more prevalent in patients with RRMS or MON compared to healthy controls.
Main Methods:
- Genotyping of the NcoI polymorphism in the TNF alpha gene.
- Comparison of allele and phenotype frequencies between patient cohorts (RRMS, MON) and a control group of healthy individuals.
- Analysis of DNA fragments to detect any structural variations associated with the disease groups.
Main Results:
- The frequency distribution of NcoI marker phenotypes did not significantly differ between healthy controls and patients with relapsing/remitting multiple sclerosis or monosymptomatic optic neuritis.
- No evidence of extra or missing DNA fragments related to the NcoI polymorphism was found in the disease groups compared to controls.
- The NcoI polymorphism in the TNF alpha gene does not appear to be a risk factor for RRMS or MON in the studied population.
Conclusions:
- The NcoI polymorphism of the tumor necrosis factor alpha gene is not associated with susceptibility to relapsing/remitting multiple sclerosis or monosymptomatic optic neuritis.
- Genetic variations at the NcoI locus of TNF alpha do not appear to play a significant role in the pathogenesis of these neurological conditions.
- Further research may be needed to explore other genetic factors or environmental influences contributing to MS and MON development.